Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors - Wikidata - awgldk - TriplyDB

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

http://www.wikidata.org/entity/Q24629458

about

Ontogenesis and localization of Ca2+ channels in mammalian skeletal muscle in culture and role in excitation-contraction coupling.Inhibition of ATP-sensitive potassium channels by haloperidol.Identification of a novel calcium antagonist binding site in rat brain by SR 33557 Selective antagonism of calcium channel activators by fluspirilene The role of atypical antipsychotics in glucose/insulin dysregulation and the evolving role of the psychiatrist in a new era of drug treatment options.Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death.P/Q-type calcium channel modulators.Calcium antagonist receptors. Clinical and physiological relevance.Molecular properties of structure and regulation of the calcium channel.Biochemistry, molecular pharmacology, and functional control of Ca2+ channels.Zebrafish as a model for cardiovascular development and disease Fluspirilene block of N-type calcium current in NGF-differentiated PC12 cells.Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes.Inhibition of glutamate release by fluspirilene in cerebrocortical nerve terminals (synaptosomes).Meiosis reinitiation of mussel oocytes involves L-type voltage-gated calcium channel.

P2860

Q33851461-6BD225A5-59E6-4C11-93B2-018C6D5ACC48 Q35048471-A80885E0-05A6-4DA3-9B48-D2ABE55E5050 Q35870980-50F721F4-1DD1-4E55-8B7F-050FA2BA4756 Q35887862-1A3D5C27-4714-4A2F-83A6-B7DE5B2666CD Q35936267-7D1D31E5-96B2-4FF0-ABEA-7CC8973B017E Q37745415-C6DD3640-C892-4699-9CEE-6E75D966A891 Q38016449-A5BE7067-300E-4263-AD37-DD3DB7C7B6FA Q38188963-BA616738-62E2-44D4-815F-933220293FBD Q38188965-4555D7E1-A11A-457C-94E9-BAEC143145A6 Q38275833-A306301D-410F-4D8D-835A-0A9E2DD0CF6A Q40574936-2F5B6DBF-D1DD-4DBF-8A10-30F1C89E425E Q41962698-EEF9E448-9A7E-493C-9F16-414940CCEF54 Q42237253-2B03CA2D-D229-40F8-9B5C-CAE4C437BBBB Q43884683-59FCC170-89E1-46DB-BAA4-9E5F583D1DF7 Q48968237-F15762A5-8B57-4FEB-B2C6-3B8A44809996

P2860

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

http://www.wikidata.org/entity/Q24629458

description

1986 nî lūn-bûn

@nan

1986 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1986 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

name

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@ast

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@en

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@nl

type

label

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@ast

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@en

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@nl

prefLabel

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@ast

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@en

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@nl

P1433

Q24629458-14BA287A-1908-41CF-B91B-5F2FBBB12028

P1476

Q24629458-9CFD7040-2AFD-4C97-95F6-55FD07E05FB0

P2093

Q24629458-3B02EC2E-7606-42A6-8161-B9E94F765169

Q24629458-5E09C9CB-6C71-485D-AFD8-C713D0BE68F7

Q24629458-85AFD936-6A52-43E8-BECE-33DDE1234952

Q24629458-A9635C68-0F0F-4716-8DAC-5432892D547C

P2860

Q24629458-1578FB74-E51E-4A86-B814-11B884F6F877

Q24629458-246CCD6B-44F9-4C76-9E53-D1410CA22350

Q24629458-32CC7678-EE93-4AF4-A5D2-70949D73714E

Q24629458-3629F2DE-BA03-4B9F-9190-5A38D92822DE

Q24629458-402F4F0F-D533-460D-8C21-E7118A3CEF76

Q24629458-64D3B693-CC09-45A9-AFFB-8595939D139B

Q24629458-6945A7D0-85E9-4838-8D4C-1FEA889ECD3F

Q24629458-87B76261-6A9E-44A0-B098-B8A48FE02490

Q24629458-94B9D1D2-78E0-445D-995D-D0ED39740146

Q24629458-9E882C8C-7350-47F7-994F-F33522005FE7

P304

Q24629458-D7766C6F-6D97-4CC1-8698-047E3411079A

P31

Q24629458-0FE3E538-E8FD-40A5-99DD-4EA3EB6FCBC9

P356

Q24629458-5CBA257D-E4E6-49EB-926A-06916A13CD37

P407

Q24629458-B0DC2C3F-CC41-45FD-B03B-A858544576F8

P433

Q24629458-88D603DB-937B-4EFC-BC89-7B02A2ECAC1B

P478

Q24629458-3E32EF0E-8C0C-480E-A4E6-4685E74F11F6

P50

Q24629458-38CB9D10-7217-407B-A220-648E58D7D881

P577

Q24629458-2BFF8D6C-F383-4A23-979A-864B0FE730A0

P5875

Q24629458-42ADF9FA-81FC-42AF-B70F-362CFDDD15AC

P698

Q24629458-11ADC72A-4CC6-41BC-8DE8-83D5EA94CF3F

P932

Q24629458-314E7B5D-428B-4FC4-83F8-58E628C9D133

P356

PNAS.83.19.7513

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

@en

P2093

G Romey

http://www.w3.org/2001/XMLSchema#string

J P Galizzi

http://www.w3.org/2001/XMLSchema#string

M Fosset

http://www.w3.org/2001/XMLSchema#string

P Laduron

http://www.w3.org/2001/XMLSchema#string

P2860

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics

Different types of Ca2+ channels in mammalian skeletal muscle cells in culture

Dihydropyridine-sensitive Ca2+ channels in mammalian skeletal muscle cells in culture: electrophysiological properties and interactions with Ca2+ channel activator (Bay K8644) and inhibitor (PN 200-110).

Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.

Are dihydropyridine binding sites voltage sensitive calcium channels?

Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites.

The 1,4-dihydropyridine receptor associated with the skeletal muscle voltage-dependent Ca2+ channel. Purification and subunit composition.

A novel type of cardiac calcium channel in ventricular cells.

Differentiation of opiate and neuroleptic receptor binding in rat brain.

P304

7513-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.83.19.7513

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Michel Lazdunski

P577

1986-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20727419

http://www.w3.org/2001/XMLSchema#string

P698

2429309

http://www.w3.org/2001/XMLSchema#string

P932

386749

http://www.w3.org/2001/XMLSchema#string